Effects of a selective neutral endopeptidase and a nonselective neutral endopeptidase/endothelin-converting enzyme inhibitor on lipopolysaccharide-induced endotoxaemia in anaesthetized Sprague-Dawley rats

Journal of Cardiovascular Pharmacology

Volumn 36, Issue 5 SUPPL. 1, 2000, Pages

  Pham, D ^a   Jeng, A Y ^a   Escher, E ^a   Sirois, P ^a   Battistini, B ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Endothelins (ETs); Endotoxaemia; Lipopolysaccharide (LPS); NEP ECE inhibitor; Rat

Indexed keywords

2 (4 BIPHENYLYL) 1 (1H TETRAZOL 5 YL)ETHYLAMINOMETHYLPHOSPHONIC ACID; CGS 24592; CREATININE; ENDOTHELIN CONVERTING ENZYME INHIBITOR; ENKEPHALINASE INHIBITOR; LIPOPOLYSACCHARIDE; UNCLASSIFIED DRUG; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; ENDOTOXEMIA; LIVER FUNCTION; LYMPHOCYTE COUNT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THROMBOCYTE COUNT; UREA BLOOD LEVEL;

EID: 0033735149     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200036001-00071     Document Type: Article

References (30)

1. Organ dysfunction following haemorrhage and sepsis: Mechanisms and therapeutic approaches
2. Modulation of circulating endothelin levels in hypertension and endotoxaemia in rats
3. Endothelin concentrations in experimental sepsis: Profiles of big endothelin and endothelin 1-21 in lethal peritonitis in rats
4. Enhancement of the hypotensive and vasodilator effects of endotoxaemia in conscious rats by the ET antagonist, SB 209670
5. Influence of aminoguanidine and the endothelin antagonist, SB 209670, on the regional haemodynamic effects of endotoxaemia in conscious rats
6. Tissue expression of endothelin-1 mRNA in endotoxaemia
7. Effects of the endothelin receptor antagonist, SB 209670, on the circulatory failure and organ injury in endotoxic shock in the anaesthetized rat
8. Effect of selective blockade of endothelin ETB receptors on the liver dysfunction and injury caused by endotoxaemia in the rat
9. Endothelin-1 in rat endotoxaemia: mRNA expression and vasoreactivity in pulmonary and systemic circulations
10. Enhanced involvement of endothelin in the haemodynamic sequelae of endotoxaemia in conscious, hypertensive, transgenic (mRen-2)27) rats
11. Endothelin A-receptor blockade worsens endotoxin-induced hepatic microcirculatory changes and necrosis
12. Elevation of plasma endothelin concentration during endotoxin shock in dogs
13. Improvement of renal dysfunction in dogs with endotoxaemia by a nonselective endothelin receptor antagonist
14. Increased plasma and pulmonary lymph levels of endothelin during endotoxin shock
15. Time course of plasma and pulmonary lymph endothelin-like immunoreactivity during sustained endotoxaemia in chronically instrumented sheep
16. An association between lung lymph endothelin concentration and survival during endotoxaemia in awake sheep
17. Role of endothelin in endotoxin-induced sustained pulmonary hypertension in sheep
18. Release of endothelin-like immunoreactivity in relation to neuropeptide Y and catecholamines during endotoxin shock and asphyxia in the pig
19. Endothelin-1 and endotoxaemia
20. Inhibitory effects of diclofenac on the endotoxin shock response in relation to endothelin turnover in the pig
21. Bosentan-improved cardiopulmonary vascular performance and increased plasma levels of endothelin-1 in porcine endotoxin shock
22. Cardiopulmonary dysfunction during porcine endotoxin shock is effectively counteracted by the endothelin receptor antagonist bosentan
23. Differentiated effects on splanchnic homeostasis by selective and non-selective endothelin receptor antagonism in porcine endotoxaemia
24. Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis
25. Plasma levels of TNF-α, endothelin-1 and thrombomodulin in patients with sepsis
26. Pharmacological profile of a non-peptidic dual inhibitor of neutral endopeptidase 24.11 and endothelin-converting enzyme
27. Measurement and significance of circulating natriuretic peptides in cardiovascular disease
28. Regional plasma levels of cardiac peptides and their response to acute neutral endopeptidase inhibition in man
29. Neutral endopeptidase modulates septic shock
30. Beneficial effects of the peptidoleukotriene receptor antagonist, SK and F 104353, on the responses to experimental endotoxaemia in the conscious rat